Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr.
Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first ...
Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended March 31, 2026. First Quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results